These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5013242)

  • 21. Small scale preparation and clinical use of factor IX-prothrombin complex.
    Barrowcliffe TW; Stableforth P; Dormandy KM
    Vox Sang; 1973 Nov; 25(5):426-41. PubMed ID: 4203167
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular changes during prothrombin activation.
    Engel AM; Alexander B
    Biochim Biophys Acta; 1973 Oct; 320(3):687-700. PubMed ID: 4796208
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the prothrombin--complex.
    Mannhalter C; Deutsch E; Högenauer E; Michl H
    Thromb Res; 1979 Jan; 14(1):67-75. PubMed ID: 570743
    [No Abstract]   [Full Text] [Related]  

  • 24. A simplified procedure for purification of human prothrombin, factor IX and factor X.
    Bajaj SP; Rapaport SI; Prodanos C
    Prep Biochem; 1981; 11(4):397-412. PubMed ID: 7312833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coagulation factor IX in normal and haemophilia B plasma.
    Somer JB; Castaldi PA
    Br J Haematol; 1970 Feb; 18(2):147-59. PubMed ID: 5439522
    [No Abstract]   [Full Text] [Related]  

  • 26. [Preparation of factor IX concentrate with the use of DEAE-cellulose and its therapeutic results].
    Uszyński L; Poszwiński P
    Acta Haematol Pol; 1971; 2(2):109-14. PubMed ID: 5170671
    [No Abstract]   [Full Text] [Related]  

  • 27. [Action of vitreous body in the blood coagulation].
    Regnault F; Larrieu MJ
    Pathol Biol (Paris); 1969 Jan; 17(1):31-7. PubMed ID: 4895968
    [No Abstract]   [Full Text] [Related]  

  • 28. Purification of blood coagulation factors II, VII, IX and X from bovine citrated plasma.
    Reekers P; Hemker HC
    Haemostasis; 1972; 1(1):2-22. PubMed ID: 4668761
    [No Abstract]   [Full Text] [Related]  

  • 29. Factor IX concentrates .
    Ménaché D
    Thromb Diath Haemorrh; 1975 Jun; 33(3):600-5. PubMed ID: 1154314
    [No Abstract]   [Full Text] [Related]  

  • 30. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential interaction of clotting factors II, VII, IX and X with sephadex and dextran blue.
    Swart AC; Kop-Klaassen BH; Hemker HC
    Haemostasis; 1972-1973; 1(5):237-52. PubMed ID: 4670119
    [No Abstract]   [Full Text] [Related]  

  • 32. Isolation and characterization of multiple forms of human thrombin.
    Gorman JJ; Castaldi PA
    Thromb Res; 1974 May; 4(5):653-73. PubMed ID: 4838247
    [No Abstract]   [Full Text] [Related]  

  • 33. No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate.
    Mannucci PM; Bauer KA; Gringeri A; Barzegar S; Santagostino E; Tradati FC; Rosenberg RD
    Br J Haematol; 1991 Dec; 79(4):606-11. PubMed ID: 1772782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated clotting factors in factor IX concentrates.
    Hultin MB
    Blood; 1979 Nov; 54(5):1028-38. PubMed ID: 497395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Removal of hepatitis B virus from a concentrate of coagulation factors II, VII, IX and X by hydrophobic interaction chromatography.
    Einarsson M; Kaplan L; Nordenfelt E; Miller E
    J Virol Methods; 1981 Nov; 3(4):213-28. PubMed ID: 7328163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of human Factor II.
    Kisiel W; Hanahan DJ
    Biochim Biophys Acta; 1973 Mar; 304(1):103-13. PubMed ID: 4633593
    [No Abstract]   [Full Text] [Related]  

  • 37. Concentration of hepatitis-B antigen from clinical preparations of II, VII, IX and X by polyethylene glycol, to enhance detection and removal.
    Johnson AJ
    Ann N Y Acad Sci; 1975 Jan; 240():162-4. PubMed ID: 234215
    [No Abstract]   [Full Text] [Related]  

  • 38. Removal of hepatitis B surface antigen (HBsAg) from plasma fractions.
    Johnson AJ; Semar M; Newman J; Harris RB; Brandt D; Middleton S; Smith J
    J Lab Clin Med; 1976 Jul; 88(1):91-101. PubMed ID: 932537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
    Raby C
    Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756
    [No Abstract]   [Full Text] [Related]  

  • 40. [The P.P.S.B. coagulant fraction].
    Soulier JP; Steinbuch M
    Nouv Presse Med; 1975 Oct; 4(36):2581-4. PubMed ID: 812061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.